Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Handling Power Failures during Machine Operations – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Handling Power Failures during Machine Operations – V 2.0

Standard Operating Procedure for Handling Power Failures during Machine Operations


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/050/2025
Supersedes SOP/SIM/050/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the standard procedure for responding to power failures that occur during machine operations in sterile injectable manufacturing, ensuring product integrity, equipment safety, and regulatory compliance.

2. Scope

This SOP applies to all

production equipment including vial fillers, syringe fillers, autoclaves, lyophilizers, and cleanroom utilities that may be affected by unexpected power interruptions within sterile manufacturing facilities.

3. Responsibilities

  • Machine Operator: Immediately stop operations and inform engineering and QA personnel.
  • Engineering Officer: Investigate and restore power supply, perform equipment checks.
  • QA Officer: Assess the impact on product quality, decide on batch status post-power recovery.
  • Shift Supervisor: Coordinate communications, document incident, and oversee restart activities.
See also  Sterile Injectable Manufacturing: SOP for Formulation Development of Intravenous Injections - V 2.0

4. Accountability

The Head of Production is accountable for ensuring all operations comply with this SOP during and after a power failure, and for reporting deviations to Quality Assurance.

5. Procedure

5.1 Identification of Power Failure

  1. Monitor alarm indicators, HMI blackout, or control panel inactivity to confirm power loss.
  2. Check other equipment and lighting in the production area to assess the extent of failure.
  3. Log the time of power failure initiation in the machine downtime record (Annexure-1).

5.2 Immediate Actions

  1. Halt any ongoing operations and ensure personnel safety by withdrawing from electrical interfaces.
  2. Secure all open containers, vials, and critical WIP (Work In Progress) under laminar flow hoods or seal containers if possible.
  3. Notify Engineering and QA teams promptly.
  4. Power down machines using E-Stop (emergency stop) if not already off to avoid sudden surges when power is restored.

5.3 Equipment Safety Checks Post-Restoration

  1. Upon restoration, Engineering must verify:
    • Main supply voltage is stable and within safe operational range.
    • No signs of short circuits, motor damage, or abnormal noise/vibration.
  2. Document power restoration time and engineer’s inspection summary in Annexure-1 and Annexure-2.
See also  Manufacturing: SOP for Documentation of In-Process Observations - V 2.0

5.4 Resuming Operations

  1. QA must assess product status (intermediate or filled units) during power loss.
  2. If the batch is under process:
    • Inspect environmental conditions and validate they remained within specifications.
    • Conduct in-process checks for fill weight, temperature, sterility zone compliance, etc.
    • QA to provide go/no-go decision documented in Annexure-3.
  3. Production may resume only after written clearance from QA and Engineering.

5.5 Documentation

  1. Fill in power failure event log (Annexure-1) and equipment inspection checklist (Annexure-2).
  2. QA shall complete post-power failure batch disposition form (Annexure-3).

5.6 Preventive Measures

  1. Ensure UPS (Uninterrupted Power Supply) is active for HMI and control units.
  2. Perform generator checks weekly and record in utility readiness log.
  3. Train production teams every 6 months on power failure response protocol.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • HMI: Human Machine Interface
  • QA: Quality Assurance
  • UPS: Uninterrupted Power Supply

7. Documents

  1. Machine Downtime Record – Annexure-1
  2. Equipment Post-Power-Check Report – Annexure-2
  3. Batch Disposition Form Post-Power Failure – Annexure-3

8. References

  • WHO TRS 961 Annex 6 – GMP for Sterile Pharmaceutical Products
  • ICH Q9 – Quality Risk Management
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
See also  Sterile Injectable Manufacturing: SOP for Conducting Operational Qualification (OQ) for Machines - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Production Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Machine Downtime Record

Date Machine ID Time of Failure Time Restored Operator Remarks
18/06/2025 INJ-FILL-03 10:20 AM 10:45 AM Ajay Sharma Power fluctuation

Annexure-2: Equipment Post-Power-Check Report

Machine ID Inspection Date Inspected By Outcome Remarks
INJ-FILL-03 18/06/2025 Sunil Patil No Damage Ready for use

Annexure-3: Batch Disposition Form Post-Power Failure

Batch No. Product Stage at Interruption QA Review Outcome Decision QA Reviewer
INJ/B23/079 Amikacin Injection Filling in Progress Within Specifications Continue Processing Meena Reddy

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release New SOP QA Head
18/06/2025 2.0 Added equipment inspection and disposition forms Annual Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: Suitability Testing for Microbial Methods – V 2.0
Next Post: BA-BE Studies: SOP for Ensuring Sample Integrity Before Analysis – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version